期 |
栏目 |
标题 |
文件 |
卷 95, 编号 9 (2023) |
Editorial |
Creation of registers as one of the mechanisms for improving medical care for patients with chronic heart failure. Problem state |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 93, 编号 9 (2021) |
Original articles |
Prognostic impact of uric acid in patients with acute decompensated heart failure |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 93, 编号 12 (2021) |
Original articles |
Myocardial remodeling in patients with chronic heart failure and implanted cardiac contractility modulators |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 93, 编号 12 (2021) |
Original articles |
Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 93, 编号 11 (2021) |
Reviews |
Pro-inflammatory cytokines in chronic cardiac failure: state of problem |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 94, 编号 4 (2022) |
Original articles |
Myocardial scintigraphy with 99mTc-pyrophosphate in the diagnosis of cardiac amyloidosis: place in the diagnostic algorithm, features of the implementation and interpretation of the study |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 94, 编号 4 (2022) |
Reviews |
SGLT2 inhibitors in acute decompensated heart failure, what do we know? |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 94, 编号 4 (2022) |
Reviews |
Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis) |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 94, 编号 9 (2022) |
Editorial |
Acute decompensation of heart failure: state of the problem |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 95, 编号 9 (2023) |
Clinical notes |
Difficulties in differential diagnosis of the AL- and ATTR-cardiac amyloidosis. Case report |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 95, 编号 4 (2023) |
Clinical notes |
A rare variant in the TTR gene (p.E112K) is associated with systemic amyloidosis and a new symptom – skin hyperemia in response to ethanol intake: family segregation analysis, literature review, and a clinical case. Case report |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 95, 编号 9 (2023) |
Original articles |
Possibilities of instrumental determination of volemic status in patients with acute decompensation of chronic heart failure |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 95, 编号 9 (2023) |
Original articles |
A clinical and economic analysis of the use of dapagliflozin in patients with chronic heart failure in the entire spectrum of left ventricular ejection fraction in the Russian Federation |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 95, 编号 9 (2023) |
Reviews |
Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 96, 编号 7 (2024): VARIO |
Original articles |
Chronic kidney disease and chronic heart failure: impact on prognosis and choice of pathogenetic therapy |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 95, 编号 12 (2023) |
Reviews |
Reunion of the main Russian schools of internal medicine: on the occasion of the centenary of the Therapeutic Archive journal. A review |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 96, 编号 4 (2024) |
Editorial |
Expert Center for cardiac amyloidosis: reality and perspectives |
![PDF](/img/labels/pdf.png) (Rus)
|